ArticleFrontiers in oncology2021

Combination of Bempegaldesleukin and Anti-CTLA-4 Prevents Metastatic Dissemination After Primary Resection or Radiotherapy in a Preclinical Model of Non-Small Cell Lung Cancer.

Amber M Bates et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.